Unveiling Ncardia's Path to Innovation and Growth

Published on July 5, 2024
Unveiling Ncardia's Path to Innovation and Growth

In this interview, we spoke to Dr. Jeroen de Groot, Ncardia’s new Divisional Chief Executive, about the past and the future of Ncardia. Continue reading to uncover Ncardia's exciting innovations and don't miss Dr. Jeroen de Groot's exclusive hint on what's ahead for the company this year!

BACKGROUND

Dr. Jeroen de Groot has a robust background in leading international contract research organizations and expertise in innovation, drug discovery, and development. He holds a biology degree from Leiden University and a PhD from Utrecht University Medical Centre. Since joining Ncardia, Jeroen has been tightly involved in leveraging Ncardia’s cutting-edge stem cell technologies to help drug innovators develop much-needed safe and efficacious therapies for patients.

 

Continue reading on website
Other news

Toll-Free-Number-for-Butte-County-Thompson-Fire-Proclamation-Issued-on-July-3-2024

July 3, 2024
On July 3, 2024, Governor Newsom issued a State of Emergency Proclamation to Butte County for the Thompson Fire that began on July 2, 2024, and has since burned 4,000 acres, prompting evacuation orders for thousands. This fire threatens structures, homes, critical infrastructure, and health, and congregate care facilities. The high temperatures and winds have increased the fire’s spread, causing i

Summary of the Whitepaper on Building Blocks for Cell & Gene Therapy (CGT)

July 8, 2024
The whitepaper, a collaboration between the Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), summarizes a Scientific Exchange held on November 1, 2023.  This event brought together CGT developers, FDA staff, and industry stakeholders to discuss development and regulatory challenges in the CGT field and identify reusabl